PharmaDepth

Company profile

AMNEAL PHARMACEUTICALS, INC.

NASDAQ:AMRXBiotechnology: Pharmaceutical Preparations

Drug pipeline (345)

AssetStageRevenueTrialsStatus
ABIRATERONE ACETATEapproved—26approved
ACEBUTOLOL HYDROCHLORIDEapproved—0—
ACETAMINOPHEN AND CODEINE PHOSPHATEapproved—78approved
ACTIVELLAapproved—21approved
ACYCLOVIRapproved—1approved

Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.

Clinical trials (15)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT03562949phase3terminated2018-12-062019-08-02Amneal Ireland LimitedA BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol
NCT06267274phase1unknown2024-04-012025-03-01Amneal Pharmaceuticals, LLCA Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
NCT03562923phase3unknown2018-10-012019-05-01Amneal Ireland LimitedA Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50
NCT02940561phase1unknown2016-08-012016-10-01Amneal Pharmaceuticals, LLCBE Study in Patients - Methotrexate Tablets
NCT02072954phase2_3completed2013-11-012014-02-01Amneal Pharmaceuticals, LLCBioequivalence Fasting Study in Patients

FDA applications (451)

ApplicationApprovedTypeApplicantProducts
NDA 2207902026-07-09NDAAMNEAL EU LTD
ANDA 2110002026-06-08ANDAAMNEAL EU LTD
ANDA 2190992026-06-02ANDAAMNEAL EU LTD
ANDA 2177342026-06-01ANDAAMNEAL EU LTD
ANDA 2174972026-05-14ANDAAMNEAL PHARMACEUTICALS LLC